Back
Gencor Industries 10K Form
Buy
62
GENC
Gencor Industries
Last Price:
21.44
Seasonality Move:
5.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-10 | 10Q | GENC/Gencor Industries Quarterly |
2024-02-06 | 10Q | GENC/Gencor Industries Quarterly |
2023-08-09 | 10Q | GENC/Gencor Industries Quarterly |
2023-05-12 | 10Q | GENC/Gencor Industries Quarterly |
2023-02-10 | 10Q | GENC/Gencor Industries Quarterly |
2022-08-12 | 10Q | GENC/Gencor Industries Quarterly |
Receive GENC News And Ratings
See the #1 stock for the next 7 days that we like better than GENC
GENC Financial Statistics
Sales & Book Value
Annual Sales: | $105.08M |
---|---|
Cash Flow: | $-1.43M |
Price / Cash Flow: | 13.91 |
Annual Sales: | $13.28 |
Price / Book: | 1.61 |
Profitability
EPS (TTM): | 1.10000 |
---|---|
Net Income (TTM): | $16.21M |
Gross Margin: | $29.04M |
Return on Equity: | 8.69% |
Return on Assets: | 8.11% |
Gencor Industries Earnings Forecast
Key Gencor Industries Financial Ratios
- The Gross Profit Margin over the past 40 years for GENC is 27.63%.
- The Selling, General & Administrative Expenses for GENC have been equal to 11.57% of Gross Profit Margin.
- The Research & Development expenses have been 3.29% of Revenue.
- The Interest Expense is 0.18% of Operating Income.
- The Net Earning history of GENC is 13.96% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 21 years.
Gencor Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | GENC |
CUSIP: | 368678 |
Website: | gencor.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 26.55 |
Quick Ratio: | 17.45 |
Price-to-Earnings
Trailing P/E Ratio: | 21.42 |
---|---|
Forward P/E Ratio: | 0 |
GENC Technical Analysis vs Fundamental Analysis
Buy
62
Gencor Industries (GENC)
is a Buy
Is Gencor Industries a Buy or a Sell?
-
Gencor Industries stock is rated a Buy
The current Gencor Industries [GENC] share price is $21.42. The Score for GENC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.